Boston Scientific (BSX) Short Interest Ratio & Short Volume $86.99 -0.60 (-0.69%) (As of 11/15/2024 ET) Add Compare Share Share Short Interest Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSustainabilityTrends Boston Scientific Short Interest DataBoston Scientific (BSX) has a short interest of 12.91 million shares. This marks a 14.15% increase in short interest from the previous month. The short interest ratio (days to cover) is 2.3, indicating that it would take 2.3 days of the average trading volume of 6.08 million shares to cover all short positions.Current Short Interest12,910,000 sharesPrevious Short Interest11,310,000 sharesChange Vs. Previous Month+14.15%Dollar Volume Sold Short$1.08 billionShort Interest Ratio2.3 Days to CoverLast Record DateOctober 31, 2024Outstanding Shares1,473,830,000 sharesPercentage of Shares Shorted0.88%Today's Trading Volume10,230,145 sharesAverage Trading Volume6,083,564 sharesToday's Volume Vs. Average168% Short Selling Boston Scientific? Sign up to receive the latest short interest report for Boston Scientific and its competitors with MarketBeat's FREE newsletter. Email Address Skip Charts & View Short Interest HistoryShort Interest ChartDays to Cover ChartShort Percent of Float ChartBSX Short Interest Over TimeBSX Days to Cover Over TimeBSX Percentage of Float Shorted Over Time Ad DTIWhy buying gold might be a mistakeSomething strange just happened with gold. With the recent Fed rate cut… My charts are showing a breakout signal I haven't seen in years. But for now, I'm not rushing to buy gold. In fact, I'm telling everyone I know to hold off. Because I believe there’s a far better way to play this upcoming surge. It's a method that could turn a 1% gold price change into gains like 59%, 118%, or even 228%. And it doesn't involve buying a single ounce of physical gold or even buying any regular gold stock. I've been trading gold for nearly 20 years now and this is my #1 recommended approach for trading gold right now. Most traders miss them completely… But for those who know how to spot them, it takes their trades to a whole new level.If you're interested, check out the recording here while the link's still up. Boston Scientific Short Interest History Export to ExcelReport DateTotal Shares Sold ShortDollar Volume Sold ShortChange from Previous ReportPercentage of Float ShortedDays to CoverPrice on Report Date 10/31/202412,910,000 shares $1.08 billion +14.2%N/A2.3 $84.02 10/15/202411,310,000 shares $981.37 million +3.6%N/A2 $86.77 9/30/202410,920,000 shares $915.10 million -10.5%N/A2 $83.80 9/15/202412,200,000 shares $1.02 billion +10.7%N/A2.2 $83.31 8/31/202411,020,000 shares $901.33 million +2.6%N/A2 $81.79 8/15/202410,740,000 shares $833.21 million -0.6%N/A1.9 $77.58 Get the Latest News and Ratings for BSX and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Boston Scientific and its competitors with MarketBeat's FREE daily newsletter. 7/31/202410,800,000 shares $797.69 million -6.3%N/A1.8 $73.86 7/15/202411,530,000 shares $899.57 million +2.5%N/A1.9 $78.02 6/30/202411,250,000 shares $866.36 million -2.5%N/A1.9 $77.01 6/15/202411,540,000 shares $885.81 million -13.8%N/A1.9 $76.76 5/31/202413,380,000 shares $1.01 billion +8.5%N/A2.2 $75.59 5/15/202412,330,000 shares $917.97 million -11.6%N/A2 $74.45 4/30/202413,940,000 shares $1.00 billion +5.9%N/A2.2 $71.86 4/15/202413,160,000 shares $887.51 million +5.9%N/A2 $67.44 3/31/202412,430,000 shares $851.33 million +8.3%N/A1.9 $68.49 3/15/202411,480,000 shares $760.32 million +21.6%N/A1.8 $66.23 2/29/20249,440,000 shares $625.02 million -14.4%N/A1.5 $66.21 2/15/202411,030,000 shares $728.97 million +1.5%N/A1.7 $66.09 1/31/202410,870,000 shares $687.64 million -4.9%N/A1.6 $63.26 1/15/202411,430,000 shares $685.11 million +22.3%N/A1.7 $59.94 12/31/20239,350,000 shares $540.52 million -19.7%N/A1.3 $57.81 12/15/202311,640,000 shares $649.63 million +26.0%N/A1.6 $55.81 11/30/20239,240,000 shares $516.42 million -22.0%N/A1.2 $55.89 11/15/202311,850,000 shares $638.12 million +29.7%N/A1.4 $53.85 10/31/20239,140,000 shares $467.88 million -32.3%N/A1.1 $51.19 10/15/202313,490,000 shares $668.02 million -7.5%N/A1.6 $49.52 9/30/202314,580,000 shares $769.82 million +22.7%N/A1.9 $52.80 9/15/202311,880,000 shares $628.45 million -2.8%N/A1.6 $52.90 8/31/202312,220,000 shares $659.15 million +40.1%N/A1.7 $53.94 8/15/20238,720,000 shares $450.65 million +4.7%N/A1.2 $51.68 7/31/20238,330,000 shares $431.91 million +13.2%N/A1.1 $51.85 7/15/20237,360,000 shares $390.30 million -13.2%N/A0.9 $53.03 6/30/20238,480,000 shares $458.51 million -2.8%N/A1 $54.07 6/15/20238,720,000 shares $470.79 million -29.5%N/A1 $53.99 5/31/202312,360,000 shares $636.29 million -23.0%N/A1.3 $51.48 5/15/202316,050,000 shares $861.56 million -10.7%N/A1.8 $53.68 4/30/202317,970,000 shares $936.60 million +16.4%N/A2.1 $52.12 4/15/202315,440,000 shares $799.33 million +1.9%N/A1.9 $51.77 3/31/202315,160,000 shares $758.45 million +5.9%N/A1.9 $50.03 3/15/202314,310,000 shares $686.45 million +12.8%N/A2 $47.97Let’s be blunt (Ad)Let me be blunt with you for just a second… You may think you know when and why stocks move, but you’re wrong… Most traders have no idea about the biggest secret Wall Street keeps — even though it’s hiding in plain sight. But once you’ve cracked this code… It could be the breakthrough you need to start targeting $100-$150 a day in the stock market (starting with just $1,000)! Check out the $100 Challenge now 2/28/202312,690,000 shares $592.88 million +29.9%N/A1.8 $46.72 2/15/20239,770,000 shares $462.02 million -26.2%N/A1.5 $47.29 1/31/202313,230,000 shares $611.89 million -15.3%N/A2 $46.25 1/15/202315,610,000 shares $726.33 million +10.6%N/A2.3 $46.53 12/30/202214,110,000 shares $652.87 million -1.7%N/A2.1 $46.27 12/15/202214,350,000 shares $664.69 million +8.8%N/A2.1 $46.32 11/30/202213,190,000 shares $597.11 million +0.2%N/A1.9 $45.27 11/15/202213,170,000 shares $558.67 million -5.3%N/A1.9 $42.42 10/31/202213,910,000 shares $599.66 million -8.6%N/A2 $43.11 10/15/202215,220,000 shares $608.50 million -8.8%N/A2.2 $39.98 9/30/202216,690,000 shares $646.40 million +3.7%N/A2.5 $38.73 9/15/202216,100,000 shares $679.42 million +5.9%N/A2.4 $42.20 8/31/202215,210,000 shares $613.12 million -9.8%N/A2.1 $40.31 8/15/202216,860,000 shares $710.65 million +22.6%N/A2.2 $42.15 7/31/202213,750,000 shares $564.44 million -14.3%N/A1.7 $41.05 7/15/202216,040,000 shares $602.30 million -2.4%N/A1.9 $37.55 6/30/202216,440,000 shares $612.72 million -13.6%N/A1.9 $37.27 6/15/202219,020,000 shares $685.29 million +25.3%1.4%2.2 $36.03 5/31/202215,180,000 shares $622.53 million +1.2%1.1%1.8 $41.01 5/15/202215,000,000 shares $594.90 million +21.5%1.1%1.7 $39.66 4/30/202212,350,000 shares $520.06 million +3.2%0.9%1.4 $42.11 4/15/202211,970,000 shares $529.67 million -23.6%0.9%1.3 $44.25 3/31/202215,670,000 shares $694.02 million +13.4%1.1%1.7 $44.29 3/15/202213,820,000 shares $589.56 million -21.5%1.0%1.5 $42.66 2/28/202217,600,000 shares $777.39 million -0.3%1.3%1.9 $44.17 2/15/202217,650,000 shares $776.78 million -3.8%1.3%1.9 $44.01 1/31/202218,340,000 shares $786.79 million +19.1%1.3%2 $42.90 1/15/202215,400,000 shares $690.84 million +1.9%1.1%1.9 $44.86 12/31/202115,120,000 shares $642.30 million +11.5%1.1%2 $42.48 12/15/202113,560,000 shares $545.65 million -7.8%1.0%1.8 $40.24 11/30/202114,700,000 shares $559.63 million -6.4%1.0%2.1 $38.07 11/15/202115,710,000 shares $649.45 million -26.0%1.1%2.4 $41.34 10/29/202121,220,000 shares $915.22 million -6.0%1.5%3.3 $43.13 10/15/202122,570,000 shares $979.54 million -5.1%1.6%3.6 $43.40 9/30/202123,790,000 shares $1.03 billion +15.8%1.7%3.7 $43.39 9/15/202120,540,000 shares $924.51 million +2.7%1.5%3.2 $45.01 8/31/202120,000,000 shares $903 million +19.0%1.4%3.2 $45.15 8/13/202116,810,000 shares $745.19 million +17.9%1.2%2.6 $44.33 7/30/202114,260,000 shares $650.26 million +15.5%1.0%2.2 $45.60 7/15/202112,350,000 shares $520.68 million -2.8%N/A1.9 $42.16 6/30/202112,710,000 shares $543.48 million -5.2%N/A1.8 $42.76 6/15/202113,400,000 shares $572.85 million +17.5%N/A1.9 $42.75 5/28/202111,400,000 shares $485.07 million -2.9%N/A1.6 $42.55 5/14/202111,740,000 shares $488.50 million -29.4%N/A1.5 $41.61 4/30/202116,620,000 shares $732.94 million +13.8%N/A2 $44.10 4/15/202114,610,000 shares $579.58 million -3.2%N/A1.7 $39.67 3/31/202115,090,000 shares $587.91 million -15.1%N/A1.6 $38.96 3/15/202117,780,000 shares $690.75 million -0.2%N/A1.8 $38.85 2/26/202117,810,000 shares $706.52 million -2.3%N/A1.5 $39.67 2/12/202118,230,000 shares $708.60 million +26.8%N/A1.5 $38.87Let’s be blunt (Ad)Let me be blunt with you for just a second… You may think you know when and why stocks move, but you’re wrong… Most traders have no idea about the biggest secret Wall Street keeps — even though it’s hiding in plain sight. But once you’ve cracked this code… It could be the breakthrough you need to start targeting $100-$150 a day in the stock market (starting with just $1,000)! Check out the $100 Challenge now 1/29/202114,380,000 shares $522.57 million -6.6%N/A1.1 $36.34 1/15/202115,400,000 shares $556.86 million +2.2%N/A1.1 $36.16 12/31/202015,070,000 shares $535.74 million -7.8%N/A1.1 $35.55 12/15/202016,340,000 shares $546.57 million +33.7%N/A1.2 $33.45 11/30/202012,220,000 shares $410.59 million -5.8%N/A1 $33.60 11/15/202012,970,000 shares $492.60 million +6.6%N/A1.2 $37.98 10/30/202012,170,000 shares $407.70 million +5.6%N/A1.3 $33.50 10/15/202011,520,000 shares $467.94 million -10.8%N/A1.5 $40.62 9/30/202012,920,000 shares $493.67 million -20.5%N/A1.8 $38.21 9/15/202016,250,000 shares $666.58 million +9.5%N/A1.9 $41.02 8/31/202014,840,000 shares $608.74 million -9.9%N/A1.6 $41.02 8/14/202016,470,000 shares $644.97 million +5.2%N/A1.7 $39.16 7/31/202015,660,000 shares $604.01 million +5.2%N/A1.5 $38.57 7/15/202014,890,000 shares $546.46 million -12.8%N/A1.4 $36.70 6/30/202017,070,000 shares $599.33 million -8.4%N/A1.5 $35.11 6/15/202018,640,000 shares $668.62 million +9.3%N/A1.6 $35.87 5/29/202017,060,000 shares $648.11 million +52.3%N/A1.4 $37.99 5/15/202011,200,000 shares $390.10 million +8.6%N/A0.9 $34.83 4/30/202010,310,000 shares $386.42 million -14.1%N/A0.9 $37.48 4/15/202012,000,000 shares $417.48 million +21.7%N/A1 $34.79 3/31/20209,860,000 shares $363.83 million -31.1%N/A0.8 $36.90 3/13/202014,308,500 shares $526.98 million +25.2%N/A1.7 $36.83 2/28/202011,430,000 shares $295.24 million +9.2%N/A1.3 $25.83 2/14/202010,470,000 shares $368.33 million -19.2%N/A1.5 $35.18 1/31/202012,960,000 shares $510.49 million +11.6%N/A1.9 $39.39 1/15/202011,610,000 shares $494.24 million -17.4%N/A1.7 $42.57 12/31/201914,050,000 shares $607.10 million -1.6%N/A2.1 $43.21 BSX Short Interest - Frequently Asked Questions What is Boston Scientific's current short interest? Short interest is the volume of Boston Scientific shares that have been sold short but have not yet been covered or closed out. As of October 31st, investors have sold 12,910,000 shares of BSX short. Learn More on Boston Scientific's current short interest. What is a good short interest ratio for Boston Scientific? The short interest ratio, also known as the "days to cover ratio", is calculated by dividing the number of shares of a stock sold short divided by its average trading volume. A short interest ratio ranging between 1 and 4 generally indicates strong positive sentiment about a stock and a lack of short sellers. A short interest ratio of 10 or greater indicates strong pessimism about a stock. BSX shares currently have a short interest ratio of 2.0. Learn More on Boston Scientific's short interest ratio. Which institutional investors are shorting Boston Scientific? As of the most recent reporting period, the following institutional investors, funds, and major shareholders have reported short positions of Boston Scientific: Barclays PLC, Jane Street Group LLC, Wolverine Trading LLC, Readystate Asset Management LP, Point72 DIFC Ltd, Point72 Asset Management L.P., Parallax Volatility Advisers L.P., Garda Capital Partners LP, Verition Fund Management LLC, Capstone Investment Advisors LLC, Walleye Trading LLC, Walleye Capital LLC, PEAK6 Investments LLC, BNP Paribas Financial Markets, Citigroup Inc., LMR Partners LLP, Genus Capital Management Inc., Caas Capital Management LP, Portman Square Capital LLP, Concourse Financial Group Securities Inc., and Valeo Financial Advisors LLC. These positions are disclosed in Form 13F filings with the Securities and Exchange Commission. Is Boston Scientific's short interest increasing or decreasing? Boston Scientific saw a increase in short interest in October. As of October 31st, there was short interest totaling 12,910,000 shares, an increase of 14.1% from the previous total of 11,310,000 shares. Changes in short volume can be used to identify positive and negative investor sentiment. Investors that short sell a stock are betting that its price will decline in the future. An increase in short sale volume suggests bearish (negative) sentiment among investors. A decrease on short sale volume suggests bullish (positive) sentiment. How does Boston Scientific's short interest compare to its competitors? Here is how the short interest of companies compare to Boston Scientific: Abbott Laboratories (0.82%), Intuitive Surgical, Inc. (1.08%), Stryker Co. (1.13%), Medtronic plc (0.80%), Becton, Dickinson and Company (0.71%), Edwards Lifesciences Co. (1.33%), ResMed Inc. (5.37%), IDEXX Laboratories, Inc. (2.57%), DexCom, Inc. (2.40%), STERIS plc (1.05%), Which stocks are the most shorted right now? As of the most recent reporting period, the following stocks had the largest short interest positions: Charter Communications, Inc. ($4.08 billion), AppLovin Co. ($3.18 billion), Paychex, Inc. ($2.64 billion), Nu Holdings Ltd. ($2.54 billion), International Paper ($2.46 billion), Cencora, Inc. ($2.27 billion), Moderna, Inc. ($1.87 billion), SoFi Technologies, Inc. ($1.81 billion), Lululemon Athletica Inc. ($1.75 billion), and Onsemi ($1.71 billion). View all of the most shorted stocks. What does it mean to sell short Boston Scientific stock? Short selling BSX is an investing strategy that aims to generate trading profit from Boston Scientific as its price is falling. BSX shares are trading down $0.60 today. To short a stock, an investor borrows shares, sells them and buys the shares back on the public market later to return it to the lender. Short sellers are betting that a stock will decline in price. If the stock does drop after selling, the short seller buys it back at a lower price and returns it to the lender. The difference between the sell price and the buy price is the trader's profit. How does a short squeeze work against Boston Scientific? A short squeeze for Boston Scientific occurs when it has a large amount of short interest and its stock appreciates in price. This forces short sellers to cover their short interest positions by buying actual shares of BSX, which in turn drives the price of the stock up even further. How often is Boston Scientific's short interest reported? Short interest is typically published by a stock exchange once per month. However, NASDAQ publishes a report for U.S. stocks, including BSX, twice per month. The most recent reporting period available is October, 31 2024. More Short Interest Resources from MarketBeat Related Companies ABT Short Squeeze ISRG Short Squeeze SYK Short Squeeze MDT Short Squeeze BDX Short Squeeze EW Short Squeeze RMD Short Squeeze IDXX Short Squeeze DXCM Short Squeeze STE Short Squeeze Short Interest Tools Stocks to Short Largest Short Interest Positions Short Interest Increases Short Interest Decreases Short Interest Reporting Dates This page (NYSE:BSX) was last updated on 11/17/2024 by MarketBeat.com Staff From Our PartnersBill Gates’s Next Big AI Bet: StargateIn February 2016… when almost nobody was talking about artificial intelligence…. I picked Nvidia as one of ...Brownstone Research | SponsoredThe Crypto That’s Making Wall Street SweatThe Crypto Wall Street Is Desperate to Hide It's happening now, right under everyone's radar. Big tech gian...Crypto 101 Media | SponsoredThere is a little known company that is changing warfareWith geo - political instability around the world investors are flocking to defense contract stocks. There...Reticulate | SponsoredTim Sykes’ Urgent Trade Alert: “Make this move now”WARNING: 80 Wall Street banks are gearing up for MASSIVE D.C. shock This $2 trillion D.C. shock is NOT abou...Timothy Sykes | SponsoredElon knows the truth, which is why they want him silencedElon Musk is one of mankind’s greatest innovators. But for all his visionary prowess and contributions to h...Porter & Company | Sponsored24/7 Automated Profits in CryptoWhat if you could make consistent daily profits in crypto with minimal effort? Beyond trading lies a vast w...Crypto Swap Profits | SponsoredTrump Wins… But Elon Says Get Ready to BraceTrump's back in the White House, ready to hit the gas on America's comeback. He's taking on the economy wi...Genesis Gold Group | SponsoredUnveiled: NVIDIA’s "Secret Royalty" ProgramDid you know that there's an investment that will give you the opportunity to collect "royalties" every time N...Behind the Markets | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Boston Scientific Co. Please log in to your account or sign up in order to add this asset to your watchlist. Share Boston Scientific With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Free BSX Stock Alerts